Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NCPC International Corporation is the primary international business arm of the North China Pharmaceutical Group (NCPC), one of the largest pharmaceutical enterprises in China. Established to manage the global distribution and marketing of NCPC's extensive product line, the company specializes in active pharmaceutical ingredients (APIs), intermediates, and finished dosage forms. Its core strengths lie in the production of antibiotics, including penicillins, cephalosporins, and aminoglycosides, as well as vitamins and biotechnology products. The corporation operates with a focus on international quality standards, holding numerous GMP certifications and regulatory approvals across various global markets. By leveraging the massive manufacturing scale of its parent group, NCPC International provides cost-effective healthcare solutions to over 100 countries and regions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NCPC International Corporation.